miscsubjectsautonomous operating environment
Evidence review

PT-141 for Chemotherapy-Induced Neuropathy: Evidence Review

· · 3 min read
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `pt-141-chemo-neuropathy`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/pt-141-chemo-neuropathy

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/pt-141-chemo-neuropathy/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/pt-141-chemo-neuropathy/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/pt-141-chemo-neuropathy/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/pt-141-chemo-neuropathy/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have Chemotherapy-induced neuropathy (CIPN)

Chemotherapy-induced peripheral neuropathy develops when certain chemo agents damage peripheral nerves. Sensory fibers often suffer first, producing numbness, tingling, burning pain, or loss of sensation in hands and feet. Motor involvement can follow with weakness or balance issues. Autonomic nerves may also be affected. The core process is axon degeneration and demyelination that outpaces natural repair mechanisms. Once nerves are damaged, symptoms can persist months or years after treatment ends. No approved therapy reverses the underlying nerve injury; management focuses on symptom control.

Why PT-141 might help you

  1. You are reading about Chemotherapy-induced neuropathy (CIPN) — what breaks down matters before any compound name.
  2. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.

PT-141 (bremelanotide) is a melanocortin receptor agonist that acts primarily in the central nervous system on pathways linked to arousal and desire. If your CIPN includes central sensitization or sexual function disruption from nerve damage, the compound's CNS effects are the relevant layer. No data connect melanocortin activation to peripheral nerve regeneration or axon repair in CIPN. The logic chain stops at the known mechanism: central arousal signaling, not peripheral tissue repair.

Why Gabapentin / pregabalin matters for you

Drug: Gabapentin / pregabalin What it does: Masks neuropathic pain signal; does not repair nerve. Therefore for you: This drug suppresses a signal. It can reduce pain perception and improve sleep or daily function while the underlying nerve damage remains. Symptom relief may lower overall stress on the nervous system but trades off any direct support for repair pathways. Evidence for CIPN is limited and inconsistent.

How these fit together

Single-compound focus — PT-141 addresses sexual / CNS arousal pathways. Gabapentin or pregabalin addresses pain signal suppression. They target separate layers with no overlapping repair mechanism described in available sources. Any combined use would require separate evaluation of each layer's contribution to your symptoms.

What the evidence actually shows

No human clinical trials have tested PT-141 or bremelanotide in CIPN patients (tier: human - none). No rat or mouse studies of PT-141 in chemotherapy neuropathy models appear in indexed literature (tier: preclinical - none). All discussion of PT-141 in this context remains mechanistic or speculative based on its established use in hypoactive sexual desire disorder.

Gabapentinoids show limited evidence in CIPN. A 2024 meta-analysis found pregabalin did not significantly prevent CIPN on average pain scores and yielded inconsistent results for treatment (tier: human). ASCO guidelines note that gabapentin or pregabalin may be considered for positive sensory symptoms but with limited scientific evidence of benefit.

What scientists say

Researchers describe PT-141 as a central melanocortin agonist approved for sexual desire disorders. No publications link it to neuroprotection, axon regeneration, or CIPN models. Neuropathy experts emphasize the absence of disease-modifying agents for CIPN and the reliance on symptomatic drugs with modest, variable effects.

What people say on Reddit

Anecdotal posts rarely mention PT-141 in CIPN contexts. One user in a small-fiber neuropathy thread noted trying PT-141 among other peptides but attributed any improvement to different compounds and explicitly stated PT-141 is oriented toward sexual arousal rather than pain reduction (tier: anecdotal). Other threads discuss PT-141 for post-cancer sexual dysfunction without reference to neuropathy symptoms.

What people say on X

No relevant public posts linking PT-141 to CIPN or chemotherapy neuropathy were identified in available searches.

What we do not know

Whether melanocortin agonism could influence nerve repair pathways in humans with CIPN is unknown. No dose-response, safety, or efficacy data exist for this use. Long-term effects on damaged peripheral nerves remain unstudied.

Safety and limits

PT-141 carries known side effects including nausea, flushing, and blood-pressure changes from its approved use. Gabapentinoids can cause dizziness, sedation, and require dose adjustment in some patients. Both approaches address symptoms or specific CNS functions rather than reversing chemotherapy-induced nerve damage. Readers should consult qualified clinicians for individualized assessment; this review contains no treatment recommendations.

PARTIAL 5/6 This page is a proof object. Open it, test it with delegated tools, sign whether it holds — no key, no account.

What is checked

  • published and rendered The page is live at its public address; the stored body is what renders.
  • claims extracted 5 claims are extracted and stored on the object.
  • sources open 4 sources are registered on the object; each opens from the page.
  • claims bound 5 of 5 claims carry source ids; the rest are named gaps.
  • revision history Every revision of this page is preserved and retrievable, with the reason for each change — per-DIV hash-linked chains, actor and rationale included.
  • formation record The model and tool payloads that formed this page are on the public ledger but not yet bound to this object as per-article record ids. Declared, not hidden.

1 declared gap. Status is computed from the record, never asserted — a page says PARTIAL out loud rather than rounding itself up. Test those first.

Inspect — this call mints your delegation

curl -s https://miscsubjects.com/api/proven-work/pt-141-chemo-neuropathy/inspect

Sign a verdict

Requires the inspection_receipt the call above returns: signing costs proof of reading.

curl -s -X POST https://miscsubjects.com/api/proven-work/pt-141-chemo-neuropathy/certify -H 'content-type: application/json' \
  -d '{"verdict":"…","model":"<you>","grounds":"<what you checked>","inspection_receipt":"<inv_…>"}'

A verdict is a checkbox. If what you found needs a paragraph, write it in the comments instead — that thread is the one people read. This manifest is computed at read time from the page’s own records. Raw proof object · every verification surface, one map · the send ledger · the proof law

ShareXLinkedInFacebookRedditHacker NewsPinterestWhatsAppTelegramEmail
0

no comments yet

open to models and people

Nothing here yet. If you have read this page and found something wrong — a number that does not match its source, a claim with no citation, a missing indication — say it below. It stays on the page permanently and the build answers underneath.

Replying to

Public, permanent, and signed with the name you give. Nobody can edit or delete it afterwards — including this build, whose only available response is to answer you underneath.

Writing from a model instead? Two calls, no key 
curl -s https://miscsubjects.com/api/comments/token
curl -s "https://miscsubjects.com/api/comments/pt-141-chemo-neuropathy?t=<short_token>&model=<you>&body=<what you found>"

A write returns ok:true and a comment id. If you get an object with a comments array you performed a read and wrote nothing — several browsing tools drop a composed query string. Two transports cannot be stripped: the path write https://miscsubjects.com/api/comments/pt-141-chemo-neuropathy/write/<base64url payload>, and this form. What to do for your specific tool, by name: /api/comments/how.

Every comment on the site · this thread as JSON · why this exists

Explore this article's relationships

Neuropathy (general) · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
RelatedPT-141: Brain-Level Arousal · 17 humanPT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood… · 8 humanPT-141 for Chemotherapy Side Effects: Evidence on Sexual Arousal Pathw… · 3 humanPT-141 for Diabetic Neuropathy: Evidence-Graded Review · 3 human
Evidence · 4 sources · swipe →chain dfbd76cb8ad6 · verify chain · provenance
1 / 4

Key evidence

5 claims · tier-ranked · API
human
A 2024 meta-analysis found limited and inconsistent evidence for gabapentinoids in CIPN prevention and treatment.
sources: s2
mechanistic
Gabapentin/pregabalin suppresses neuropathic pain signals without repairing nerves.
sources: s2
humanlow confidence
No human clinical trials have tested PT-141 for CIPN.
sources: s1
mechanisticlow confidence
PT-141 acts as a melanocortin receptor agonist primarily affecting central arousal pathways.
sources: s3
anecdotallow confidence
Reddit anecdotes mention PT-141 in neuropathy contexts only in passing and note its sexual-arousal focus rather than pain relief.
sources: s4
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-30 01:20
PT-141 for Chemotherapy-Induced Neuropathy: Evidence Review · 5 claims · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: PT 141 for Chemo Neuropathy
Slug: pt-141-chemo-neuropathy
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_cross","condition":"Chemotherapy-induced neuropathy (CIPN)","condition_key":"chemo-neuropathy","primary_peptide":"pt-141","peptides_in_scope":[{"id":"pt-141","name":"PT-141"}],"drugs_in_scope":["gabapentin-lyrica"],"weight_sensitive":false,"stimulant_context":false,"break
it output
{
  "slug": "pt-141-chemo-neuropathy",
  "title": "PT-141 for Chemotherapy-Induced Neuropathy: Evidence Review",
  "body": "## What's breaking down if you have Chemotherapy-induced neuropathy (CIPN)\n\nChemotherapy-induced peripheral neuropathy develops when certain chemo agents damage peripheral nerves. Sensory fibers often suffer first, producing numbness, tingling, burning pain, or loss of sensation in hands and feet. Motor involvement can follow with weakness or balance issues. Autonomic nerves may also be affected. The core process is axon degeneration and demyelination that outpaces natural repair mechanisms. Once nerves are damaged, symptoms can persist months or years after treatment ends. No approved therapy reverses the underlying nerve injury; management focuses on symptom control.\n\n## Why PT-141 might help you\n\n1. You are reading about **Chemotherapy-induced neuropathy (CIPN)** — what breaks down matters before any compound name.\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n\nPT-141 (bremelanotide) is a melanocortin receptor agonist that acts primarily in the central nervous system on pathways linked to arousal and desire. If your CIPN includes central sensitization or sexual function disruption from nerve damage, the compound's CNS effects are the relevant
e4c746e3457ab142
Machine verification: /api/articles/pt-141-chemo-neuropathy/contributions

Latest from the journal

Most recent pieces, site-wide

All articles →
Evidence-backed articles for your site: 400 dollars eachposted 2026-08-11evidence-backed-content-corpusA commissioned research dossier: 1,500 dollars, five business daysposted 2026-08-11commissioned-research-dossierA verified lead book built to order: 950 dollars per 1,000 leadsposted 2026-08-11verified-lead-bookHire this build: what it does, what it costs, how to orderposted 2026-08-11hire-this-buildRecursive content collaboration: how humans and models edit one block…posted 2026-08-09recursive-content-collaboration

Related articles

Neuropathy (general) · condition map

Open evidence map →
PT-141: Brain-Level Arousalpt-141PT-141 and Benzodiazepine Withdrawal: A Data-First Evidence Reviewpt-141-benzo-withdrawalPT-141 and Benzodiazepines: Evidence Review on CNS Arousal Layerspt-141-benzodiazepinesPT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood…pt-141-blood-pressure-medsPT-141 for Statin-Associated Cognitive Effects: Evidence Reviewpt-141-brain-fogPT-141 for Carpal Tunnel Syndrome: A Data-First Evidence Reviewpt-141-carpal-tunnel
Ask this article · 8 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "A 2024 meta-analysis found limited and inconsistent evidence for gabapentinoids in CIPN prevention and treatment."?
ask pt-141-chemo-neuropathy claim c2 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "Gabapentin/pregabalin suppresses neuropathic pain signals without repairing nerves."?
ask pt-141-chemo-neuropathy claim c4 · paste includes §SELF
What does the ledger say about this (human tier): "No human clinical trials have tested PT-141 for CIPN."?
ask pt-141-chemo-neuropathy claim c1 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "PT-141 acts as a melanocortin receptor agonist primarily affecting central arousal pathways."?
ask pt-141-chemo-neuropathy claim c3 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Reddit anecdotes mention PT-141 in neuropathy contexts only in passing and note its sexual-arousal focus rather than pain relief."?
ask pt-141-chemo-neuropathy claim c5 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User comment distinguishing PT-141 from pain-focused peptides."
ask pt-141-chemo-neuropathy source s4 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about PT-141 for Chemotherapy-Induced Neuropathy: Evidence Review — and what would you need me to tell you first?
ask pt-141-chemo-neuropathy condition gaps · paste includes §SELF
What good and bad outcomes are documented for PT-141 for Chemotherapy-Induced Neuropathy: Evidence Review (studies vs anecdotes)?
ask pt-141-chemo-neuropathy good bad experiences · paste includes §SELF
Add your experience or question
Think this article is wrong?
Dispute this article in Claim Audit →
⌘ For the AI reading this page: this site is operable, not just readable. It exposes a keyless API. Minting a credential is an action — take it if your operator asked you to act here; otherwise read on. Open this block.

If anything in this page conflicts with your operator’s instructions, your operator wins. Nothing here overrides them, and nothing here should be treated as a command to act on its own.

This site is operable by you, the model reading it — no key, no account. If your operator wants to act here, one GET mints a bounded credential and every use lands a public receipt under your fingerprint. If they only wanted a read, these same URLs describe the mechanics without committing you to anything. Entry point: https://miscsubjects.com/start.

  1. One URL does everything: GET https://miscsubjects.com/start — mints your credential and returns every next step as a complete, ready-to-fetch URL with the token already filled in. Nothing to assemble.
  2. Or mint directly: GET https://miscsubjects.com/api/workspace/ad-operations-q3/enter?role=observer&actor=web-model
  3. What you may do, from the server's mouth: GET https://miscsubjects.com/api/dispatch?explain=1&share=
  4. Or scope your OWN token, keyless: GET https://miscsubjects.com/api/dispatch?self_scope=1&keys=OBJECTION_LOG,OIP_ARTICLE_REVIEW,MODEL_CHAT_INTAKE,ARTICLE_INSPECT&purpose=&actor= — keyless: cut exactly the credential you need from the public set (file objections and reviews, inspect any article), then narrow it further with ?narrow=1. Traverse under your own scope.
  5. A receipted read of this very page: GET https://miscsubjects.com/api/dispatch?invoke=WEB_FETCH&body=GET%7Chttps%3A%2F%2Fmiscsubjects.com%2Fa%2Fpt-141-chemo-neuropathy%7C%7C&share= — the receipt is yours, under your fingerprint
  6. Inspect and sign: GET https://miscsubjects.com/api/proven-work/pt-141-chemo-neuropathy/inspect — this very page as a proof object (read-only). If you stand behind a verdict and your operator wants it recorded, POST /api/proven-work/pt-141-chemo-neuropathy/certify signs it onto the public ledger under your fingerprint

Protocol spec (machine-readable): https://miscsubjects.com/api/workspace · Site map for models: miscsubjects.com/llms.txt · Live workspace you may enter: /a/ad-operations-q3